Skip to content

Comparison the analgesic efficacy of Lidocaine/Dexamethasone and Lidacaine/ Fentanyl in Forearm Fracture through Axillary Block

Comparison of Postoperative Pain Management in Forearm Fracture with Lidocaine/Dexamethasone and Lidacaine/ Fentanyl through Axillary Block Technique

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012120711687N1
Enrollment
58
Registered
2013-07-22
Start date
2012-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia following the operation of forearm fracture. Fracture of upper end of ulna Incl.: Coronoid process Elbow, NOS, Monteggia fracture-dislocation Olecranon process Proximal end. Fracture of upper end of radius Incl.: Head Neck Proximal end. Fracture of shaft of ulna. Fracture of shaft of radius. Fract

Interventions

Intervention 1: Group 2 case:Lidocaine 1% (40 ml) + fentanyl 100 µg (2 ml). Intervention 2: Control group: Lidocaine 1% (40 ml) + dH2O (2 ml. Intervention 3: Group 1 case: Lidocaine 1% (40 ml) + dexam
Treatment - Other
Treatment - Drugs
Group 2 case:Lidocaine 1% (40 ml) + fentanyl 100 µg (2 ml).
Control group: Lidocaine 1% (40 ml) + dH2O (2 ml
Group 1 case: Lidocaine 1% (40 ml) + dexamethasone (2 ml),

Sponsors

Vice chancellor for research, Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Following inclusion criteria were considered: (a) Elective nature of surgery, presence of forearm fracture (b) Performance of surgery at Rajaei Hospital (c) Absence of underlying diseases such as coagulopathy, peripheral vascular diseases, and neuropathy (d) Patient’s full agreement on performing axillary anesthesia (e) Lack of any history of allergy to local anesthetics (f) Lack of treatment with palliative drugs and those affecting the CNS (g)Non-addict, and (h) Suitability of patients to be placed (classified) in ASA I&II classes. Also, the exclusion criteria employed were (a) operation duration of more than 90 min and b) the appearance of pain during the surgery

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Total analgesic dose administered during 6 hrs after the surgery. Timepoint: During 6 hrs after the surgery. Method of measurement: Visual analogue scale.

Secondary

MeasureTime frame
Duration of sensory block. Timepoint: The time interval between the time of loss of pain sensation at forearm to reappearance of paresthesia. Method of measurement: Pin-prick test.;Time of duration of motor block. Timepoint: the time interval between the time of loss of pain sensation at forearm to complete recovery of motor function. Method of measurement: Gripping force test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahyar Seddighi

Vice chancellor for research, Qazvin University of Medical Sciences

mahyarseddighi@ gmail.com ; dr_msa_md@ yahoo.com+98 28 1334 4507

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 9, 2026